← Back to Search

Behavioral Intervention

MyPEEPS Mobile Plus for HIV Prevention

N/A

Recruiting

Led By Robert Garofalo, MD, MPH

Research Sponsored by Columbia University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

17-25 years of age

Male sex assigned at birth

Must not have

Transgender identity

Currently report consistent use of PrEP

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 6-month follow-up, 12-month follow-up

Awards & highlights

No Placebo-Only Group

Summary

"This trial aims to use a mobile app to provide HIV prevention information to young men who have sex with men (YMSM). The researchers want to see if combining this app with virtual peer support will

Who is the study for?

This trial is for young men who have sex with men (YMSM), considered at high risk for HIV. Participants should be interested in using mobile technology and virtual peer support to help prevent HIV infection.

What is being tested?

The study tests 'MyPEEPS Mobile Plus', a mobile intervention, combined with virtual PrEP Peer Navigation, aiming to increase use of PrEP medication and reduce risky behaviors related to HIV.

What are the potential side effects?

Since this trial involves educational interventions rather than drugs, traditional side effects are not expected. However, participants may experience increased screen time due to the use of mobile technology.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 17 and 25 years old.

Select...

I was assigned male at birth.

Select...

I have had unprotected anal sex with a male in the last year.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I identify as transgender.

Select...

I regularly take PrEP medication.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 6-month follow-up, 12-month follow-up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 6-month follow-up, 12-month follow-up

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6-month follow-up, 12-month follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

PrEP Initiation

Secondary study objectives

PrEP Adherence

PrEP Persistence

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment2 Interventions

Participants randomized to the intervention arm will have access to the MyPEEPS mobile application and Electronic peer PrEP navigation for the entire 12-month study period.

Group II: ControlActive Control1 Intervention

Participants randomized to the control arm will receive standard of care information regarding sexual and other behaviors that potentiate one's risk for HIV infection, receipt of a fact sheet about PrEP and PEP, referrals to the local PrEP clinic, and referrals for local sexually transmitted disease testing, and will have access to the MyPEEPS Mobile App during the study.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

MyPEEPS Mobile

2018

N/A

~770

0 / 5Eligibility criteria met